Meta Pixel

News and Announcements

White Rock Minerals (ASX:WRM) Received Confirmation of the Value of its Silver-Zinc Deposits in Alaska (US) and Gold Deposit in Victoria (AU)

  • Published April 07, 2022 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Fundamental Research Corp – Canada’s largest independent research house – has updated their research on White Rock. They have now factored in the recent expansion of White Rock’s high-grade silver-rich zinc Vendor Management System (VMS) project at Red Mountain in Alaska, and its recent high-grade gold hits at Morning Star in Victoria, and reiterated their valuation of A$0.90 (versus last traded of $0.20).

The analysts, Sid Rajeev, B.Tech, CFA, MBA, and Nina Rose Coderis, BSc (Geology), wrote: “We believe Red Mountain’s resource is one of the highest-grade silver-zinc VMS deposits in the world“, and on Morning Star that “Due to the project’s existing infrastructure, White Rock should be able to put the project back into production quickly after delineating a resource“.

See the full report – here.

Register Interest

Recent drilling at Dry Creek (Alaska) has doubled the high-grade Inferred Mineral Resource to 4.9 million tonnes at 8.4% zinc equivalent or 393g/t silver equivalent (at a 3% Zn cut-off) from just an additional 12 drill holes for 3,800 metres.

The Red Mountain Project now comprises two significant deposits at Dry Creek and West Tundra Flats with a combined high-grade Inferred Resource of 11.6 million tonnes at 12.0% zinc equivalent or 555g/t silver equivalent, at a 3% Zn cut-off.

The global Inferred Mineral Resource increased 27% and now totals 21.3 million tonnes at 8.5% zinc equivalent for 1.8Mt of contained zinc equivalent or 393g/t silver equivalent for 207Moz of contained silver equivalent.

Impressive overall base metal and precious metal content with 822,000t zinc (1.8B lbs), 334,000t lead, 60.9 million ounces silver and 442,000 ounces gold.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now